Proportion of isolates with resistance to ciprofloxacin reported to in Estonia
Estonia: Proportion of isolates with resistance to ciprofloxacin reported to was 42.9 in 2018. ◆ Volatile
Latest (2018)
42.9
Change on year
down 14.2%
World rank
41st
of 54 countries
All-time high
50
in 2017
All-time low
0
in 2016
Years of data
5
2014–2018
Proportion of isolates with resistance to ciprofloxacin reported to in Estonia, 2014–2018
Source: World Health Organization, Global Health Observatory.
Analysis
Estonia recorded 42.9 for proportion of isolates with resistance to ciprofloxacin reported to in 2018.
That represents a change of down 14.2% on the previous year and up 178.8% over five years.
Estonia ranks 41st of 54 countries on this measure, in the bottom quarter.
Proportion of isolates with resistance to ciprofloxacin reported to in Estonia, year by year
| Year | Value | Change |
|---|---|---|
| 2014 | 15.38 | — |
| 2015 | 27.78 | +80.6% |
| 2016 | 0 | -100.0% |
| 2017 | 50 | — |
| 2018 | 42.9 | -14.2% |
Estonia compared with similar countries
- Estonia's 42.9 is below the median for high income countries, which is 55.25, 78% of the median. (34 countries reporting)
- Estonia's 42.9 is below the median for Europe & Central Asia, which is 50.75, 85% of the median. (24 countries reporting)
Countries ranked near Estonia
More health data for Estonia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.02 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,416 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.8 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.34 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with resistance to ciprofloxacin reported to in Estonia?
- Proportion of isolates with resistance to ciprofloxacin reported to in Estonia was 42.9 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to ciprofloxacin reported to recorded in Estonia?
- The highest recorded value was 50 in 2017.
- What is the lowest proportion of isolates with resistance to ciprofloxacin reported to recorded in Estonia?
- The lowest recorded value was 0 in 2016.
- How does Estonia rank for proportion of isolates with resistance to ciprofloxacin reported to?
- Estonia ranks 41st out of 54 countries with data for 2018.
- Where does this Estonia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).